Published in Stat Med on May 14, 1986
Confidence intervals and sample sizes: don't throw out all your old sample size tables. BMJ (1991) 2.60
A predictive probability design for phase II cancer clinical trials. Clin Trials (2008) 1.37
Statistics from the inside. 13. Probability and decisions. Arch Dis Child (1994) 1.18
Sample size: how many patients are necessary? Br J Cancer (1995) 1.15
Sample size calculation for clinical trials: the impact of clinician beliefs. Br J Cancer (2000) 0.98
Bayesian communication: a clinically significant paradigm for electronic publication. J Am Med Inform Assoc (2000) 0.88
The utility of Bayesian predictive probabilities for interim monitoring of clinical trials. Clin Trials (2014) 0.87
How can we design trials to detect clinically important changes in disease severity? Br J Clin Pharmacol (1988) 0.80
A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials. Contemp Clin Trials (2013) 0.79
The use of Bayesian hierarchical models for adaptive randomization in biomarker-driven phase II studies. J Biopharm Stat (2015) 0.76
Sample size determination for a binary response in a superiority clinical trial using a hybrid classical and Bayesian procedure. Trials (2017) 0.75
Assurance calculations for planning clinical trials with time-to-event outcomes. Stat Med (2013) 0.75
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet (1992) 11.50
Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol (2001) 11.17
Laparoscopic versus open inguinal hernia repair: randomised prospective trial. Lancet (1994) 6.91
Reliability of league tables of in vitro fertilisation clinics: retrospective analysis of live birth rates. BMJ (1998) 5.96
Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol (1997) 5.73
Tables of the number of patients required in clinical trials using the logrank test. Stat Med (1983) 5.34
Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer (1978) 5.25
Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol (1994) 5.02
On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics (1976) 3.82
Bayesian approaches to random-effects meta-analysis: a comparative study. Stat Med (1995) 3.71
Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res (1978) 3.51
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98
Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Stat Med (2002) 2.86
Screening for treatable diabetic retinopathy: a comparison of different methods. Diabet Med (1991) 2.76
Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome. Lancet (1992) 2.64
Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet (2004) 2.63
Implications of a new dietary measurement error model for estimation of relative risk: application to four calibration studies. Am J Epidemiol (1999) 2.40
Monitoring of large randomised clinical trials: a new approach with Bayesian methods. Lancet (2001) 2.35
Empirical evidence of correlated biases in dietary assessment instruments and its implications. Am J Epidemiol (2001) 2.33
Mapping the densities of malaria vectors within a single village. Acta Trop (1995) 2.31
Statistical methodology for evaluating gastrointestinal symptoms. Clin Gastroenterol (1985) 2.29
Injuries sustained on "bouncy castles". BMJ (1992) 2.20
Probabilistic prediction in patient management and clinical trials. Stat Med (1987) 2.10
Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J (1995) 2.09
Outcome in neonates with Ebstein's anomaly. J Am Coll Cardiol (1992) 1.99
Issues in data monitoring and interim analysis of trials. Health Technol Assess (2005) 1.96
Histological grade and other prognostic factors in relation to survival of patients with breast cancer. Br J Cancer (1979) 1.92
Estimating the true extent of cognitive decline in the old old. J Am Geriatr Soc (1999) 1.90
The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee. Stat Med (1994) 1.90
Flexible random-effects models using Bayesian semi-parametric models: applications to institutional comparisons. Stat Med (2007) 1.90
Potential impact of genetic testing on cancer prevention trials, using breast cancer as an example. J Natl Cancer Inst (1995) 1.84
Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79
Comparison of Bayesian with group sequential methods for monitoring clinical trials. Control Clin Trials (1989) 1.79
Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut (1994) 1.64
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol (1996) 1.63
Interpreting precursor studies: what polyp trials tell us about large-bowel cancer. J Natl Cancer Inst (1994) 1.61
Can energy adjustment separate the effects of energy from those of specific macronutrients? Am J Epidemiol (1994) 1.56
A relative cost-effectiveness analysis of different methods of screening for diabetic retinopathy. Diabet Med (1991) 1.55
Risk stratification for open heart surgery. BMJ (1992) 1.51
Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer (1991) 1.49
The use of a Kolmogorov--Smirnov type statistic in testing hypotheses about seasonal variation. J Epidemiol Community Health (1979) 1.49
Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies. Health Econ (1992) 1.46
Bayesian monitoring of phase II trials in cancer chemoprevention. J Clin Epidemiol (1999) 1.41
A database on dyspepsia. Gut (1994) 1.41
A stratified Wilcoxon-type test for trend. Stat Med (1990) 1.40
The future of prognostic factors in outcome prediction for patients with cancer. Cancer (1992) 1.39
Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). Br Med J (Clin Res Ed) (1988) 1.39
Application of Bayesian statistics to decision making during a clinical trial. Stat Med (1992) 1.35
Use of risk-adjusted CUSUM and RSPRT charts for monitoring in medical contexts. Stat Methods Med Res (2003) 1.35
Stopping rules for clinical trials incorporating clinical opinion. Biometrics (1984) 1.33
Effect of starvation on the tissue composition of the small intestine in the rat. Am J Physiol (1968) 1.31
Randomised comparative studies in the treatment of cancer in the United Kingdom: room for improvement? Lancet (1979) 1.29
Variations in the level of reporting by hospitals to a regional cancer registry. Br J Cancer (1978) 1.29
Management of women with a cervical smear showing a mild degree of dyskaryosis: a review of policy. Cytopathology (1992) 1.27
Randomized, placebo-controlled, double-blind study of low-dose oral interferon-alpha in HIV-1 antibody positive patients. J Acquir Immune Defic Syndr (1992) 1.27
An assay for dopamine-beta-hydroxylase activity in tissues and serum. Experientia (1971) 1.26
Computer aided decision making in medicine. Br Med J (Clin Res Ed) (1984) 1.24
Effects of an ambient air pollution intervention and environmental tobacco smoke on children's respiratory health in Hong Kong. Int J Epidemiol (1996) 1.23
Approximate cross-validatory predictive checks in disease mapping models. Stat Med (2003) 1.22
Setting the minimal metrically detectable change on disability rating scales. Arch Phys Med Rehabil (1997) 1.19
Cytomegalovirus infection in cardiac transplant recipients associated with chronic T cell subset ratio inversion with expansion of a Leu-7+ TS-C+ subset. Clin Exp Immunol (1985) 1.18
Multivariate analysis of prognostic factors for operable rectal cancer. Lancet (1984) 1.18
Survival analysis in observational studies. Stat Med (1997) 1.17
The what, why and how of Bayesian clinical trials monitoring. Stat Med (1994) 1.16
The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics. Cancer Epidemiol Biomarkers Prev (1996) 1.15
Estimation of population pharmacokinetics using the Gibbs sampler. J Pharmacokinet Biopharm (1995) 1.14
Monitoring clinical trials: conditional or predictive power? Control Clin Trials (1986) 1.14
An analysis of repeated biopsies following cardiac transplantation. Stat Med (1984) 1.14
Interplay between design and analysis for behavioral intervention trials with community as the unit of randomization. Am J Epidemiol (1995) 1.13
A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet (2003) 1.13
Using routine intelligence to target inspection of healthcare providers in England. Qual Saf Health Care (2009) 1.12
Evaluation of a diagnostic algorithm for heart disease in neonates. BMJ (1991) 1.11
Domiciliary thrombolysis by general practitioners. BMJ (1992) 1.11
Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res (1997) 1.11
An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma. Br J Cancer (1987) 1.10
System delay in breast cancer in whites and blacks. Am J Epidemiol (1995) 1.09
Breast cancer in thyroid disease: fact or fallacy? Lancet (1981) 1.08
Applying Bayesian ideas in drug development and clinical trials. Stat Med (1993) 1.07
Validation of intermediate end points in cancer research. J Natl Cancer Inst (1990) 1.07
Serum dopamine-beta-hydroxylase activity in neuroblastoma. N Engl J Med (1972) 1.05
Improving the quality of data in randomized clinical trials: the COMPACT computer package. COMPACT Steering Committee. Stat Med (1988) 1.03
Comparison between two districts of the effects of an air pollution intervention on bronchial responsiveness in primary school children in Hong Kong. J Epidemiol Community Health (1998) 1.02
A comparison of radiotherapy alone with radiotherapy and CCNU in cerebral glioma. Clin Oncol (1978) 1.02
How does computer-aided diagnosis improve the management of acute abdominal pain? Ann R Coll Surg Engl (1992) 1.02
Evaluation of clinical decision-aids, with an application to a system for dyspepsia. Stat Med (1984) 1.02
Changing patterns of coeliac disease frequency: an analysis of Coeliac Society membership records. Gut (1985) 1.00
Checking for completeness of 24-h urine collection using para-amino benzoic acid not necessary in the Observing Protein and Energy Nutrition study. Eur J Clin Nutr (2013) 0.99
Energy adjustment methods for nutritional epidemiology: the effect of categorization. Am J Epidemiol (1994) 0.99
Interpretation of energy adjustment models for nutritional epidemiology. Am J Epidemiol (1993) 0.99
Changes in human serum dopamine- -hydroxylase activity with age. Nature (1972) 0.98
Sample size calculation for clinical trials: the impact of clinician beliefs. Br J Cancer (2000) 0.98
Bayesian design and analysis of two x two factorial clinical trials. Biometrics (1997) 0.98
Limitations of mortality data as a guide to comparative lung cancer incidence within an urban area. Public Health (1979) 0.97
Conditional logistic regression with sandwich estimators: application to a meta-analysis. Biometrics (1998) 0.97
Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. Bone Marrow Transplant (2010) 0.97
Measurement error and dietary intake. Adv Exp Med Biol (1998) 0.96